Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 2, 2015 | CEO | 5,000 | $108.44 | Sell | $542,200.00 | |
March 2, 2015 | SVP | 23,000 | $108.31 | Sell | $2,491,130.00 | |
Jan. 9, 2015 | CEO | 2,000 | $94.14 | Sell | $188,280.00 | |
Dec. 24, 2014 | CEO | 5,000 | $88.73 | Sell | $443,650.00 | |
Dec. 10, 2014 | CEO | 2,000 | $95.00 | Sell | $190,000.00 | |
Dec. 4, 2014 | Director | 7,500 | $89.90 | Sell | $674,250.00 | |
Dec. 2, 2014 | VP | 11,950 | $90.91 | Sell | $1,086,374.50 | |
Nov. 25, 2014 | SVP | 20,000 | $89.75 | Sell | $1,795,000.00 | |
Nov. 25, 2014 | CEO | 2,000 | $90.00 | Sell | $180,000.00 | |
Nov. 12, 2014 | CEO | 1,000 | $81.51 | Sell | $81,510.00 | |
Nov. 10, 2014 | EVP | 20,000 | $86.55 | Sell | $1,731,000.00 | |
Nov. 10, 2014 | CEO | 4,000 | $87.00 | Sell | $348,000.00 | |
Nov. 3, 2014 | CEO | 3,000 | $85.33 | Sell | $255,990.00 | |
Nov. 3, 2014 | SVP | 47 | $83.54 | Sell | $3,926.38 | |
Oct. 30, 2014 | EVP | 75,425 | $81.34 | Sell | $6,135,069.50 | |
Oct. 24, 2014 | CEO | 2,000 | $80.00 | Sell | $160,000.00 | |
Sept. 19, 2014 | SVP | 17,536 | $69.75 | Sell | $1,223,136.00 | |
Sept. 2, 2014 | CFO | 16,000 | $69.83 | Sell | $1,117,280.00 | |
Aug. 20, 2014 | CEO | 5,000 | $70.00 | Sell | $350,000.00 | |
Aug. 5, 2014 | EVP | 10,000 | $65.00 | Sell | $650,000.00 | |
Aug. 1, 2014 | CFO | 2,229 | $61.76 | Sell | $137,663.04 | |
July 2, 2014 | CFO | 2,229 | $64.00 | Sell | $142,656.00 | |
June 4, 2014 | CEO | 2,000 | $61.20 | Sell | $122,400.00 | |
May 22, 2014 | CEO | 1,000 | $56.88 | Sell | $56,880.00 | |
May 21, 2014 | CEO | 1,545 | $56.19 | Sell | $86,813.55 | |
May 16, 2014 | SVP | 1,004 | $56.91 | Sell | $57,137.64 | |
May 16, 2014 | EVP | 1,864 | $56.86 | Sell | $105,987.04 | |
May 16, 2014 | Director | 1,700 | $56.87 | Sell | $96,679.00 | |
May 13, 2014 | EVP | 1,434 | $58.23 | Sell | $83,501.82 | |
May 9, 2014 | EVP | 3,479 | $57.91 | Sell | $201,468.89 | |
Feb. 3, 2014 | EVP | 10,000 | $67.70 | Sell | $677,000.00 | |
Dec. 24, 2013 | CEO | 10,000 | $68.71 | Sell | $687,100.00 | |
Dec. 5, 2013 | CEO | 5,000 | $69.70 | Sell | $348,500.00 | |
Oct. 16, 2013 | CEO | 2,000 | $67.73 | Sell | $135,460.00 | |
Oct. 10, 2013 | CEO | 3,000 | $66.76 | Sell | $200,280.00 | |
Sept. 19, 2013 | EVP | 10,000 | $80.19 | Sell | $801,900.00 | |
Sept. 16, 2013 | CEO | 2,000 | $73.08 | Sell | $146,160.00 | |
Sept. 9, 2013 | EVP | 20,000 | $73.00 | Sell | $1,460,000.00 | |
Sept. 5, 2013 | EVP | 10,000 | $70.00 | Sell | $700,000.00 | |
Sept. 4, 2013 | CFO | 9,000 | $69.00 | Sell | $621,000.00 | |
Aug. 15, 2013 | CEO | 1,000 | $64.36 | Sell | $64,360.00 | |
July 1, 2013 | CFO | 4,066 | $59.78 | Sell | $243,065.48 | |
July 1, 2013 | EVP | 10,000 | $60.00 | Sell | $600,000.00 | |
June 3, 2013 | EVP | 1,098 | $58.32 | Sell | $64,035.36 | |
May 23, 2013 | EVP | 20,609 | $66.29 | Sell | $1,366,170.61 | |
May 22, 2013 | VP | 3,103 | $67.12 | Sell | $208,273.36 | |
May 21, 2013 | CEO | 2,000 | $64.14 | Sell | $128,280.00 | |
May 16, 2013 | CEO | 12,000 | $67.90 | Sell | $814,800.00 | |
May 14, 2013 | SVP | 20,000 | $70.34 | Sell | $1,406,800.00 | |
May 14, 2013 | VP | 4,947 | $70.35 | Sell | $348,021.45 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.